Valeo Financial Advisors LLC Acquires New Position in Molina Healthcare, Inc. (NYSE:MOH)

Valeo Financial Advisors LLC acquired a new stake in shares of Molina Healthcare, Inc. (NYSE:MOH) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,181 shares of the company’s stock, valued at approximately $344,000.

A number of other large investors also recently modified their holdings of the company. Summit Trail Advisors LLC purchased a new position in shares of Molina Healthcare during the 4th quarter valued at about $452,000. Wingate Wealth Advisors Inc. purchased a new position in shares of Molina Healthcare during the 4th quarter valued at about $52,000. Savant Capital LLC purchased a new position in shares of Molina Healthcare during the 4th quarter valued at about $225,000. Entropy Technologies LP raised its holdings in shares of Molina Healthcare by 58.1% during the 4th quarter. Entropy Technologies LP now owns 4,594 shares of the company’s stock valued at $1,337,000 after buying an additional 1,688 shares in the last quarter. Finally, Empirical Finance LLC raised its holdings in shares of Molina Healthcare by 53.8% during the 4th quarter. Empirical Finance LLC now owns 4,632 shares of the company’s stock valued at $1,348,000 after buying an additional 1,621 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

MOH has been the topic of a number of analyst reports. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $350.00 price target (down from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Truist Financial decreased their price target on Molina Healthcare from $400.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. UBS Group decreased their price target on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, October 24th. Finally, Robert W. Baird decreased their price target on Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Molina Healthcare has an average rating of “Hold” and a consensus price target of $355.67.

Molina Healthcare Stock Performance

NYSE MOH opened at $272.28 on Tuesday. The stock has a 50-day simple moving average of $294.57 and a two-hundred day simple moving average of $315.79. The firm has a market capitalization of $15.57 billion, a P/E ratio of 13.33, a PEG ratio of 0.94 and a beta of 0.54. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $423.92. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.55 and a current ratio of 1.62.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. On average, equities analysts forecast that Molina Healthcare, Inc. will post 24.5 earnings per share for the current year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.